Moderna | BiotechTV

Moderna’s Head of R&D explains how mRNA is being tested with other emerging cancer modalities

Stephen Hoge explains how Moderna is partnering on programs that include CAR-T, TCRs, bi-specifics, and in-vivo editing programs.

Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York

Stéphane Bancel comments on the fall covid vaccine rollout, pushing into earlier stages of cancer, and rare diseases.

Stéphane Bancel discusses Moderna's personalized cancer vaccine at #JPM23

Moderna CEO Stéphane Bancel discusses his company's personalized cancer vaccine on Day Two of #JPM23 in San Francisco.

Noubar Afeyan on Moderna and Biotech Innovation

Flagship Pioneering's Noubar Afeyan describes what it was like to navigate the pandemic as Chairman of Moderna.